Connect with us

Technology

NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA

Published

3 months ago

on

Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward increased knowledge of MS care and patient support connections

NEW YORK, June 3, 2026 /PRNewswire/ — The National Multiple Sclerosis Society today announced early progress in increasing access to comprehensive, quality care in South Carolina, where people living with MS travel an average of 66 miles to reach access to specialty care. These barriers can delay diagnosis and treatment, accelerating irreversible disease progression and disability.

The work in South Carolina is part of the National MS Society’s MS Care Desert Initiative, made possible through a historic sponsorship with Genentech, a member of the Roche Group. Building on more than 10 years of collaboration, this sponsorship represents Genentech’s largest corporate commitment to date for the Society’s healthcare access initiatives. Through Genentech’s broader sponsorship, the MS Care Desert Initiative specifically focuses on addressing critical gaps in MS care across the United States, with pilot programs in Wisconsin, South Carolina, and Mississippi, where specialty MS care is limited.

An estimated 14,800 people in South Carolina are currently living with MS. Nationally, nearly 23% of Americans live in an MS specialist desert.

“Geography should never determine the quality or timeliness of MS care,” said Leslie Ritter, SVP, Advocacy & Access to MS Care at the National MS Society. “What we’re seeing in South Carolina shows that when you invest in community-based efforts and strong partnerships, you can connect people to care faster. Every delay in diagnosis costs people function and independence—this work is helping change that.”

Building Infrastructure Where It Matters Most

In South Carolina, the National MS Society has partnered with Prisma Health, the Medical University of South Carolina (MUSC), and the South Carolina Community Health Worker Association on distinct initiatives to build MS care capacity, train healthcare professionals, and connect patients to specialized support through the MS Navigator program — the Society’s personalized support service connecting people living with MS to information, resources and care.

In the year prior to the initiative, MUSC submitted just one referral to the Society’s MS Navigator program. Since launching in 2025, engagement and collaboration between the Society and the neuroimmunology team at MUSC through the initiative have increased that number to 270—demonstrating how stronger referral pathways and intentional outreach can rapidly connect patients to support.

“MS is a disease where early intervention can make a meaningful difference. The sooner we can connect someone to specialized care, the better their long-term outcomes. What we are building in South Carolina — through partnerships, community education and better referral pathways — aims to create a more connected and supportive journey for people living with MS,” said Sonia Kaur Singh, MD, Assistant Professor, Multiple Sclerosis and Neuroimmunology, Department of Neurology, Medical University of South Carolina.

Early impact in South Carolina:

Prisma Health:Launch of the first neurospecialized MS rehabilitation program within Prisma Health in the Midlands, including the creation of a Newly Diagnosed Support Group connecting patients to care and resourcesReferrals for people living with MS to neurospecialized rehabilitation through the MS Program have more than doubled compared to pre-initiativeMedical University of South Carolina:270 MS Navigator referrals from MUSC (up from one pre-launch)Women’s Health and Multiple Sclerosis through the Lifespan educational eventSouth Carolina Community Health Worker Association:Launched the development of MS-specific training for community health workers to expand patient-centered, culturally responsive care statewide and create a scalable national model.

A Partnership to Improve the Health and Journey of People living with MS in Neurology Deserts

The South Carolina pilot is part of a three-state initiative that also includes active programs in Wisconsin and Mississippi. Each pilot represents a distinct approach to addressing barriers to MS care— from leveraging comprehensive clinical data in Wisconsin to building provider education infrastructure through the Mississippi State Medical Association. Together, these pilots are helping identify scalable solutions to address MS care gaps nationwide.

“Every day without appropriate treatment matters when you’re living with MS. The work underway in South Carolina is critical to understanding how we can connect patients with specialty care much faster,” said David Jones, Senior Medical Director at Genentech. “Genentech is proud to partner with the National MS Society and its partners: MUSC, Prisma Health and the South Carolina Community Health Worker Association. By stripping away the hurdles to early diagnosis and treatment, we can truly transform long-term health outcomes and help people live healthier, fuller lives.”

As the National MS Society enters a bold new era in its 80th year, the South Carolina pilot reflects exactly the kind of transformative, systems-level work that will accelerate progress like never before. Information about the MS Care Desert Initiative and how to connect with an MS Navigator is available at nationalMSsociety.org.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.

About the National Multiple Sclerosis Society

The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalmssociety.org, Facebook, X (formerly known as Twitter), Instagram, YouTube or 1-800-344-4867.

About Genentech

Founded 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/national-ms-society-community-partners-show-early-impact-in-closing-multiple-sclerosis-care-gaps-in-south-carolina-302789274.html

SOURCE National Multiple Sclerosis Society

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Epsilor’s New Ultra High Capacity 6T Batteries for Military Vehicles Outperform Market with 4,400Wh/174Ah Energy Capacity

Published

47 minutes ago

on

September 2, 2026

By

Epsilor’s COMBATT 6T battery provides the highest energy density and capacity in the world. MIL-PRF-32356C compliant and NATO standard, Epsilor’s newest 6T is currently under production and will be showcased at the International Defence Industry Exhibition (MSPO) in Kielce, Poland, September 8 – 11, 2026.

KIELCE, Poland, Sept. 2, 2026 /PRNewswire/ — Epsilor Electric Fuel Ltd., an Ignium company and world-recognized developer and manufacturer of smart Li-Ion batteries and charging solutions, announced that its flagship COMBATT ELI-52526-GM 6T has entered full production. MIL-PRF- 32565C and NATO-standard compliant, Epsilor’s 6T battery supplies the highest energy in its category at 4,400Wh / 174Ah.

Epsilor’s COMBATT 6T battery is designed for military vehicles, deployable tactical autonomous power systems, mobile command posts, tactical shelters, and deployable weapon systems. The COMBATT ELI-52526-GM 6T with the highest energy in its class enables longer silent watch missions while reducing fuel consumption, maintenance requirements and overall vehicle lifecycle costs. The ruggedized battery pack is designed for harsh military environments to support modern hybrid vehicle architectures, high-power payloads, electronic warfare systems, sensors, and communications equipment.

“Our goal was to redefine what users can expect from their 6T battery on the battlefield,” said Ronen Badichi, General Manager & CEO of Epsilor Electric Fuel. “Growing demand among our defense customers for higher energy 6T batteries pushed us to expedite production and we are proud to introduce this product ahead of schedule.”

“Demand for energy is always a challenge,” said Merav Kolody Shubeli, Sr. Director of International Sales at Epsilor. “We accelerated the scale-up process from development to battery production to meet the needs of our clients.”

The COMBATT 6T will be displayed at MSPO alongside Epsilor’s full range of military batteries and chargers with the highest energy density.

About Epsilor

Epsilor Electric Fuel Ltd. is a world recognized developer and producer of smart batteries, chargers, and mobile power management systems for defense, aerospace, medical, transportation, industrial, and marine applications. 

About Ignium

Ignium is a purpose-built merchant provider of components and solutions for current and next-generation weapons systems to the U.S. and allied defense industrial base.

To learn more, visit Epsilor (www.epsilor.com), or follow us on LinkedIn.

Contact:
Merav Kolody Shubeli,
Senior Director, International Sales & Marketing
Epsilor Electric Fuel Ltd.
merav.ks@epsilor.com
+972-52-8600364

 

View original content:https://www.prnewswire.co.uk/news-releases/epsilors-new-ultra-high-capacity-6t-batteries-for-military-vehicles-outperform-market-with-4-400wh174ah-energy-capacity-302867377.html

Continue Reading

Technology

Fibocom Launches RU311 5G RedCap Module Series for Streamlined 5G Upgrades in Mid-Tier IoT

Published

47 minutes ago

on

September 2, 2026

By

SHENZHEN, China, Sept. 2, 2026 /PRNewswire/ — For many IoT devices, upgrading to 5G is not simply about achieving higher bandwidth. Industrial gateways, security and surveillance systems, aftermarket automotive applications, energy applications and MiFi devices often have different priorities. Reliable connectivity, power efficiency, cost and product development efficiency can matter just as much.

To address these requirements, Fibocom has launched the RU311 5G RedCap module series. The new series offers customers a practical option for upgrading mid-tier IoT devices from 4G to a streamlined 5G architecture.

Built on the UNISOC V527 platform, the RU311 supports 5G RedCap and is also compatible with LTE Cat.4. It provides a flexible upgrade path between traditional 4G and higher-end 5G for mid-tier IoT applications.

A Streamlined Path to 5G for Mid-Tier IoT Devices

For these devices, the key to a 5G upgrade is not simply higher speed. The more important question is whether 5G can meet actual application requirements with the right balance of performance, power consumption and cost.

The RU311 supports dual-mode 5G RedCap and LTE Cat.4 connectivity. In 5G RedCap mode, it delivers peak downlink speeds of up to 226 Mbps and uplink speeds of up to 120 Mbps. In LTE mode, peak speeds reach 150 Mbps downlink and 50 Mbps uplink.

These data rates can support applications such as status reporting, remote control, video uplink, mobile broadband access and industrial data transmission.

For customers planning product upgrades, the RU311 balances 5G evolution with power and cost considerations. It helps existing mid-tier IoT devices transition more smoothly from 4G to 5G.

Compatible Design Reduces Upgrade Effort

The challenge of upgrading a device often extends beyond the wireless standard itself. Manufacturers may also need to redesign the motherboard, adapt interfaces, complete testing and validation, and manage a new product introduction cycle.

The RU311 LGA variant comes in a compact 32 mm × 29 mm × 2.4 mm package. Its pin layout is designed with compatibility considerations for Fibocom’s FG132 RedCap module and NL668/L716 Cat.4 modules. This makes it easier for customers to develop 4G and 5G products on compatible hardware designs.

For customers with existing 4G platforms, this approach can reduce hardware migration and repetitive development work. It also allows more development resources to be focused on application experience, use-case adaptation and product introduction.

Multiple Form Factors Accelerate Product Development

The RU311 series is available in LGA, M.2 and Mini PCIe form factors to support different device designs and development stages.

The M.2 variant is suited for rapid validation and platform integration. The Mini PCIe variant can be integrated into industrial gateways, routers, industrial PCs and embedded platforms. These options can reduce hardware adaptation work and accelerate product development.

The RU311 series supports protocols including TCP/UDP, HTTP/HTTPS, SSL and MQTT. It also provides interfaces such as USB, UART, RGMII, SDIO, I2C, SPI and GPIO.

Together, these capabilities support key functions across device connectivity, remote operations and maintenance, data transmission and platform integration.

“RedCap further expands the application potential of 5G in the mid-tier IoT market. It gives more devices a new technology option for balancing performance, power consumption and cost,” said a representative from UNISOC.

“The Fibocom RU311 is built on the UNISOC V527 platform. We will continue to deepen our collaboration with Fibocom and jointly expand the application scope and ecosystem of RedCap technology.”

Kony Li, General Manager of Fibocom’s MTC Business Unit, said, “As IoT devices evolve from 4G to 5G, different types of devices require connectivity capabilities that match their specific business needs. The RU311 further expands Fibocom’s 5G RedCap portfolio.”

“Going forward, Fibocom will continue working with UNISOC to advance RedCap product innovation. We aim to provide customers with a broader range of adaptable 5G connectivity options and support the continued evolution of different types of IoT devices.”

The launch of the RU311 series further strengthens Fibocom’s multi-platform, multi-form-factor 5G RedCap portfolio. It will also help accelerate RedCap adoption across a broader range of mid-tier IoT applications.

About Fibocom

Fibocom, founded in 1999, is China’s first wireless communication module company listed on both the A-share and H-share markets. Fibocom leverages wireless communication and artificial intelligence as its core technologies to provide integrated hardware and software solutions that empower industry applications. These solutions accelerate the transformation from “Connect Everything” to “Intelligent Connectivity” across diverse industries.

Fibocom’s one-stop solutions encompass cellular communication, AI, automotive, and GNSS modules, as well as AI toolchains, supporting industry-side and mainstream large model integration, and providing AI Agent, global connectivity, and cloud services, driving the digital intelligence upgrades in industries such as robotics, consumer electronics, low-altitude economy, intelligent transportation, smart retail, and smart energy.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fibocom-launches-ru311-5g-redcap-module-series-for-streamlined-5g-upgrades-in-mid-tier-iot-302867472.html

SOURCE Fibocom Wireless Inc.

Continue Reading

Technology

BTL Establishes New Laser Division and Introduces EXOLASE ONE® – The World’s First Fused Erbium Laser

Published

47 minutes ago

on

September 2, 2026

By

Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation.

PRAGUE, Sept. 2, 2026 /PRNewswire/ — BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corporate history: the official establishment of its dedicated laser division and the upcoming launch of its flagship laser system, EXOLASE ONE®.

EXOLASE ONE® is a major leap in the aesthetic industry as the first-ever application of fused erbium laser technology in medical practice. The system fuses multiple erbium laser wavelengths into a single beam of light, treating the exact same spot simultaneously. This creates a completely new form of laser-tissue interaction that overcomes the traditional limitations of existing facial rejuvenation lasers regarding clinical efficacy, speed of treatment, and patient comfort.

“The technology covers what normally requires multiple ablative and non-ablative systems, transforming it into a remarkably simple procedure that treats the entire face in under 10 minutes while delivering superior results for our patients,” said Dr. Reha Yavuzer, one of the first clinical investigators for the platform.

EXOLASE ONE® is the latest high-tech breakthrough originating from BTL’s extensive R&D infrastructure, which has powered many of the company’s industry-defining innovations.

“This is a historic moment for BTL. From the beginning, we knew that only a genuinely disruptive technology would allow us to build a true laser powerhouse,” said Tomas Schwarz, CEO of BTL Group of Companies. “Based on feedback from pioneering clinical centers worldwide, EXOLASE ONE® represents exactly this kind of breakthrough.”

Following an early-access program for selected key opinion leaders, EXOLASE ONE® will move to a broader global launch in 2027, initially focused on aesthetic medicine and dermatology. The new laser division becomes BTL’s sixth core division, complementing its existing operations in aesthetics, mental wellness, rehabilitation, cardiology, and robotics.

About BTL

Founded in 1993, BTL has grown to become one of the world’s major medical and aesthetic equipment manufacturers. With over 5,000 employees located in more than 90 countries, BTL has revolutionized the industry by offering the most advanced non-invasive solutions for body shaping, skin tightening, facial rejuvenation, mental health, rehabilitation and cardiology. BTL’s pioneering brands include EMSCULPT NEO®, EMFACE®, EMSELLA®, EXOMIND® and many others. For more information about BTL and its portfolio of medical innovations, please visit www.btlaesthetics.com.

Press team: media@btlnet.com 

 

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/btl-establishes-new-laser-division-and-introduces-exolase-one–the-worlds-first-fused-erbium-laser-302867440.html

Continue Reading

Trending